PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$5.50
Tradestie Score
48
Market Cap
$871.90M
Revenue Growth
0.9%
Analyst Upside
+257.0%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$14.09
|
$626.91M | - | 45 | Compare |
|
KROS
Keros Therapeutics, Inc. Common Stock
|
$11.22
|
$620.60M | - | 46 | Compare |
|
SVRA
Savara Inc.
|
$4.19
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.36
|
$552.46M | - | 66 | Compare |
|
VSTM
Verastem, Inc.
|
$9.83
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.39
|
$540.97M | - | 57 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.79
|
$529.35M | 11.4 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.40
|
$512.39M | - | 46 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.79
|
$505.12M | 2.8 | 59 | Compare |
More PHAT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry